Explaining the cardiovascular risk associated with rheumatoid arthritis: traditional risk factors versus markers of

Daniel H Solomon1, Joel Kremer, Jeffrey R Curtis

  • 1Brigham and Women's Hospital, Boston Massachusetts 02115, USA. dhsolomon@partners.org

Insights

Both traditional cardiovascular risk factors and rheumatoid arthritis severity markers predict cardiovascular events in RA patients. Increasing numbers of both factor types are associated with higher cardiovascular event risk.

Area of Science:

  • Rheumatology
  • Cardiology
  • Epidemiology

Background:

  • Cardiovascular disease poses a significant threat to patients with rheumatoid arthritis (RA).
  • The distinct contributions of traditional cardiovascular risk factors and RA disease activity markers to cardiovascular event prediction remain unclear.

Purpose of the Study:

  • To evaluate the relative importance of traditional cardiovascular risk factors and rheumatoid arthritis severity markers in predicting cardiovascular events.
  • To assess the combined predictive power of these factors for cardiovascular outcomes in RA patients.

Main Methods:

  • A prospective longitudinal cohort study utilizing data from the CORRONA registry in the USA.
  • Analysis of baseline data from 10,156 RA patients to identify predictors of cardiovascular outcomes (myocardial infarction, stroke, transient ischemic attack).
  • Logistic regression and receiver operating characteristic (c-statistic) analysis were used to assess the discriminatory value of traditional cardiovascular risk factors and RA severity markers.

Main Results:

  • During a median follow-up of 22 months, 76 primary cardiovascular events occurred (rate: 3.98 per 1000 patient-years).
  • The predictive model's discriminatory ability (c-statistic) improved from 0.57 (CV risk factors only) to 0.67 (CV risk factors + age/gender) and 0.71 (CV risk factors + RA severity markers).
  • Individuals with higher numbers of both traditional cardiovascular risk factors and RA severity markers exhibited a significantly increased incidence of cardiovascular events.

Conclusions:

  • Both traditional cardiovascular risk factors and rheumatoid arthritis severity markers are significant contributors to cardiovascular event prediction models in RA patients.
  • An increasing burden of both traditional cardiovascular risk factors and RA disease activity markers is associated with a progressively higher risk of cardiovascular events.
Abstract

Related Concept Videos

Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies01:22

Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies

The key clinical manifestations of Rheumatic heart disease (RHD) include several distinct cardiac symptoms.Carditis, a hallmark of acute rheumatic fever, involves inflammation of the heart's endocardium, myocardium, and pericardium. Chronic RHD often results from recurrent episodes of carditis. Its symptoms include the following:Murmurs are caused by valvular damage, especially to the mitral and aortic valves. Mitral stenosis or regurgitation is common, with characteristic heart murmurs...
Rheumatic Heart Disease I: Introduction01:23

Rheumatic Heart Disease I: Introduction

Rheumatic heart disease or RHD is a chronic condition that results from rheumatic fever, causing permanent damage to the heart valves.Etiology and Risk FactorsIt primarily arises from rheumatic fever, an inflammatory disease that can develop after untreated or inadequately treated group A streptococcal (GAS) pharyngitis. Streptococcus spreads through direct contact with oral or respiratory secretions. While the bacteria are the causative agents, factors like malnutrition, overcrowding, poor...
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers01:19

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers

Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
Rheumatic Heart Disease IV: Nursing Management01:20

Rheumatic Heart Disease IV: Nursing Management

AssessmentA comprehensive assessment is essential in managing a patient with rheumatic heart disease (RHD). Begin with obtaining a detailed medical history, including recent streptococcal infections, a history of rheumatic fever, or previously diagnosed rheumatic heart disease. Assess the patient for symptoms such as fever, chest pain, widespread joint pain (arthralgia), tachycardia, pericardial friction rub, muffled heart sounds, heart murmurs, peripheral edema, subcutaneous nodules, and...
Rheumatic Heart Disease III: Medical Management01:21

Rheumatic Heart Disease III: Medical Management

Rheumatic heart disease (RHD) management can be divided into two main strategies: prevention and long-term management.Primary PreventionPrimary prevention focuses on timely diagnosis and management of group A streptococcal pharyngitis to prevent acute rheumatic fever. The most widely used antibiotic for treating this condition is intramuscular benzathine penicillin G.Acute Rheumatic Fever TreatmentThe primary treatment goal for a patient diagnosed with acute rheumatic fever is to suppress the...